Toggle Nav
Close
  • Menu
  • Setting

Signaling Pathways

10 Items

per page
  1. Ondansetron HCl
    A5166 Ondansetron HCl
    Target: 5-HT3 Receptors
    Summary: 5-HT3 receptor antagonist
      insoluble in EtOH; insoluble in H2O; ≥33.04 mg/mL
  2. Paliperidone
    A8496 Paliperidone
    Target: 5-HT2 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|Histamine H1 Receptors
    Summary: Dopamine receptor antagonist
      insoluble in H2O; insoluble in EtOH; ≥10.662 mg/mL
  3. Clozapine
    B2235 Clozapine
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 Receptors
    Summary: 5-HT receptor antagonist
      insoluble in H2O; ≥14.95 mg/mL
  4. Olanzapine
    B2240 Olanzapine
    Target: 5-HT2 Receptors|D2 Receptors
    Summary: Antagonist of 5-HT2A and dopamine D2 receptors
      insoluble in H2O; ≥15.6 mg/mL
  5. Aripiprazole
    B2232 Aripiprazole
    Target: 5-HT1 Receptors
    Summary: 5-HT receptor partial agonist
      ≥22.4 mg/mL
  6. Loxapine
    B1001 Loxapine
     1 Citation
    Target: 5-HT2 Receptors
    Summary: 5-HT receptor antagonist
      ≥55.6 mg/mL
  7. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: Dopamine receptor antagonist
      insoluble in H2O; insoluble in EtOH; ≥11.03 mg/mL
  8. Lurasidone HCl
    B1477 Lurasidone HCl
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: Dopamine D2/5-HT2A/5-HT7/5-HT1A inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.11 mg/mL
  9. Pergolide mesylate
    B1485 Pergolide mesylate
    Target: D1 and D5 Receptors|D2 Receptors
    Summary: Dopaminergic agonist
      insoluble in EtOH; insoluble in H2O; ≥6.84 mg/mL
  10. Chlorpromazine HCl
    B1480 Chlorpromazine HCl
    Summary: dopamine receptor antagonist
      ≥17.77 mg/mL

10 Items

per page